Rolex Worn during WWII 'Great Escape' Sells for $189,000 in New York

A Rolex sold at auction in New York was worn by a British prisoner during the real-life "Great Escape" from the Nazi Stalag Luft III concentration camp in 1944 TIMOTHY A. CLARY AFP/File
A Rolex sold at auction in New York was worn by a British prisoner during the real-life "Great Escape" from the Nazi Stalag Luft III concentration camp in 1944 TIMOTHY A. CLARY AFP/File
TT

Rolex Worn during WWII 'Great Escape' Sells for $189,000 in New York

A Rolex sold at auction in New York was worn by a British prisoner during the real-life "Great Escape" from the Nazi Stalag Luft III concentration camp in 1944 TIMOTHY A. CLARY AFP/File
A Rolex sold at auction in New York was worn by a British prisoner during the real-life "Great Escape" from the Nazi Stalag Luft III concentration camp in 1944 TIMOTHY A. CLARY AFP/File

A Rolex watch worn by a British prisoner during the real-life "Great Escape" from the Nazi Stalag Luft III prisoner-of-war camp sold for $189,000 on Thursday in New York.

The final sum for the timepiece, sold to an anonymous buyer, was less than the $200,000 and $400,000 expected by Christie's, AFP said.

The watch was worn by Gerald Imeson on the night of March 24, 1944, when a group of Allied soldiers undertook the daring escape that inspired the 1963 movie starring Steve McQueen.

Imeson had ordered the watch from Rolex in Switzerland, who shipped it via the Red Cross to the prison camp near the present-day Polish town of Zagan, Christie's said.

The steel watch with a black luminous dial and hands was "instrumental in the planning and execution" of their bid for freedom, the auction house added.

Christie's said it believed Imeson's watch helped calculate the time it would take the prisoners to crawl through tunnels used in the breakout as well as timing the patrols of the camp guards.

Imeson wore the Oyster Chronograph watch as he waited 172nd in line to escape, according to Christie's.

Of the 200 prisoners who participated in the plan, 76 briefly escaped. Imeson was not among them. All but three of the men were captured and 50 were executed.

Imeson was liberated from another POW camp at the end of the war in 1945.

He wore the watch until his death in 2003 at the age of 85. It was first auctioned in Britain in 2013.

The watch was sold along with several other items, including a Royal Air Force whistle and a membership card for The Goldfish Club -- reserved for pilots and crew who have crash landed into the sea and survived.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”